Medicus Pharma MDCX
NASDAQ MDCX
$0.27 0.00 (-0.15%)
At close: Aug 21, 2026 · 4:00 PM EDT

Medicus Pharma (MDCX) Change in Account Payables (2024 - 2025)

Medicus Pharma's (MDCX) quarterly Change in Account Payables came in at -$26604.0 in Q4 2025, down 103.2% YoY from $831273.0 in Q4 2024, and up 93.42% on a QoQ basis from -$404049.0 in Q3 2025.

Medicus Pharma (MDCX) Change in Account Payables (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has 2 years of Change in Account Payables data on file, last reported at -$26604.0 in Q4 2025.

  • Quarterly Change in Account Payables fell 103.2% year-over-year to -$26604.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$25983.0 (down 103.21% YoY) and the FY2025 annual result came in at -$25983.0, down 103.21% from the prior year.
  • Change in Account Payables climbed to -$26604.0 in Q4 2025, from -$404049.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $831273.0 in Q4 2024 to a low of -$404049.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 18.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Medicus Pharma 14.88 Mn -298,205.43 - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -26,604.00
Dec 31, 2025 -26,604.00
Sep 30, 2025 -404,049.00
Sep 30, 2025 -404,049.00
Jun 30, 2025 428,914.00
Jun 30, 2025 428,914.00
Mar 31, 2025 -24,244.00
Mar 31, 2025 -24,244.00
Dec 31, 2024 831,273.00
Dec 31, 2024 831,273.00
Sep 30, 2024 8,322.00
Sep 30, 2024 8,322.00
Jun 30, 2024 -78,116.00
Jun 30, 2024 -78,116.00
Mar 31, 2024 47,266.00
Mar 31, 2024 47,266.00